SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Industrial: What resources have increased in price since the call for "anti-industrialization"?
Soochow: Lightweight materials break through, optimistic about magnesium alloy, PEEK, PA nylon leading the transformation of humanoid Siasun Robot&Automation.
Guotai Haitong: Policy strengthens insurance asset long-term assessment mechanism, benefiting long-term profit improvement.
Industrial: What resources have increased in price since the call for "anti-industrialization"?
Soochow: Lightweight materials break through, optimistic about magnesium alloy, PEEK, PA nylon leading the transformation of humanoid Siasun Robot&Automation.
Guotai Haitong: Policy strengthens insurance asset long-term assessment mechanism, benefiting long-term profit improvement.
